Table 2.
Results of the clinical tests in both groups at baseline and post-treatment.
| Hospital URI group | Home (H) group | Interaction | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Post | Baseline | Post | Kruskal-Wallis | ||||||
| Test | Mean | SD | Mean | SD | Mean | SD | Mean | SD | χ2 | p-value |
| BBT | 44.6 | 9.3 | 49.1 | 9.8 | 52.9 | 12.9 | 56.6 | 13.6 | 3.38 | 0.066 |
| UPDRS III | 31.2 | 10.9 | 28.8 | 10.9 | 24.6 | 6.3 | 22.9 | 7.3 | 5.08 | 0.024* |
| JHFT | 67.7 | 24.4 | 63.2 | 25.9 | 50.8 | 13.5 | 44.5 | 9.8 | 7.76 | 0.005* |
| Bartlett's | T-Test | Cohen's | Bartlett's | T-Test | Cohen' | |||||
| χ2/p-value | p-value | U3 | CI [x-y] | χ2/p-value | p-value | U3 | CI [x-y] | |||
| BBT | 0.052/0.820 | 0.003* | 0.57 | −7.37 | 0.017/0.896 | 0.204 | 0.42 | −10.09 | ||
| UPDRS III | 0.0001/0.997 | 0.005* | 0.33 | 0.77 | 0.110/0.739 | 0.011* | 0.43 | 0.55 | ||
| JHFT | 0.066/0.797 | 0.068 | 0.26 | −0.38 | 0.559/0.455 | 0.015* | 0.29 | 1.70 | ||
p < 0.05 statistical significant difference.